PharmaShots | Incisive News in 3 Shots

Subscribe Now

Teva

Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

January 14, 2025

Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

October 4, 2024

Insights+ Key Biosimilars Events of May 2024

Insights+ Key Biosimilars Events of May 2024

June 4, 2024

Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

May 20, 2024

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

April 17, 2024

Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of Neurology

Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of N...

October 17, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us